Anti-infective Drugs Market: Increase in Prevalence of Infectious Diseases across the Globe to Drive the Market

Wilmington, Delaware, United States: The global anti-infective drugs market is driven by increase in prevalence of infectious diseases across the globe. The global market was valued at US$ 106.5 Bn in 2016 and is projected to expand at a CAGR of 4.2% from 2017 to 2025 to reach US$ 153.3 Bn by 2025. Growth of the market is attributed to increase in digitization of dental practices, high health care IT budgets, and rise in demand for chair time optimization in developed markets.

Read Report Overview - https://www.transparencymarketresearch.com/antiinfective-drugs-market.html

Anti-infective drugs are used for the purpose of killing and/or suppressing the infection causing organisms from invading the host organism by means of replication or releasing variety of toxins in the host. Such infection causing micro-organisms include viruses, bacteria, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on the type of organism causing infection and the symptoms and medical signs shown by host.

High prevalence and incidence rates of infectious diseases, especially viral infection, and newer drug introductions have resulted in increase in growth of global anti-infective drugs market. These factors are projected to drive demand for anti-infective drugs in the near future. Moreover, rapidly growing antibacterial resistance and unmet medical needs within antiviral therapy are expected to fuel the growth of the anti-infective drugs market.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41204

Anti-infective Drugs Market: Segmentation

The global anti-infective drugs market has been segmented based on type, indication, distribution channel, and region. In terms of type, the global market has been categorized into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. The anti-viral drugs segment accounted for significant share of the global market in terms of revenue in 2016. The segment is expected to expand at a rapid pace during the forecast period. It is likely to gain market share by the end of 2025. This is attributed to increase in prevalence of viral infection, especially HIV infection, hepatitis virus infection, and others.

In terms of indication, the global anti-infective drugs market has been classified into pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, respiratory virus infection, and others.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41204

The HIV infection segment dominated the global market and the trend is likely to continue by the end of 2025 with marginal increase in market share. The HIV infection segment is projected to dominate the global anti-infective drugs market as these drugs are administered to patients for the lifetime and new and effective treatments are being introduced. Based on distribution channel, the global market has been divided into hospital pharmacy, retail pharmacy and online pharmacy.

Get COVID-19 Analysis on Anti-infective Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41204

Geographically, the global anti-infective drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2025. The region’s dominance of the global anti-infective drugs market is due to factors such as increase in adoption of advanced and high cost drug therapies and significant treatment penetration.

Moreover, patients with HIV infection and hepatitis virus infection have increased in the U.S. This is projected to fuel the growth of the anti-infective drugs market in the country during the forecast period. Asia Pacific is projected to be the fastest growing market for anti-infective drugs during the forecast period. India dominated the anti-infective drugs market in the region, whereas Japan is estimated to grow at a high CAGR during the forecast period.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=41204

Key players in the global anti-infective drugs market include Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson. Companies are adopting the strategy acquisition and collaboration to improve and strengthen geographic presence.

More Trending Reports by Transparency Market Research –

Nonalcoholic Steatohepatitis Therapeutics Market: Nonalcoholic Steatohepatitis Therapeutics Market (Drug Type: Obeticholic Acid (OCA), Aramchol (Arachidyl Amido Cholanoic Acid), Saroglitazar, and Elafibranor) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Psoriasis Treatment Market: Psoriasis Treatment Market (Drug Class: TNF Inhibitors, Interleukin Inhibitors, Vitamin D Analogs, Corticosteroids, and Others; and Route of Administration: Oral, Parenteral, and Topical) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Life Science Reagents Market: Life Science Reagents Market (Product: Chromatography Reagents, Molecular Diagnostics Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell & Tissue Culture Reagents, Hematology & Hemostasis Reagents, Microbiology Reagents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Liquid Filled Hard Capsules Market: Liquid Filled Hard Capsules Market (Size: Large Capsules, Medium Capsules, and Small Capsules) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Antihypertensive Drugs Market: Antihypertensive Drugs Market (Therapy Type: Diuretics, Angiotensin Converting Enzyme Inhibitor, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

U.S. Controlled Substance Market: Controlled Substance Market (Product Type: Opioids, Stimulants, Depressants, and Cannabinoids) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Tablet Coatings Market: Tablet Coatings Market (Polymer Type: Cellulosic Polymers, Vinyl Derivatives, Acrylic Polymers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Cannabinoids Market: Cannabinoids Market (Product Type: Cannabinoids, Tetrahydrocannabinol, Cannabinol, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

About Us

Transparency Market Research is a global market research firm offering the latest market research reports and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Rohit Bhisey

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Back to news